Ambulatory Polysomnography (PSG) Systems - Worldwide

The global ambulatory polysomnography (PSG) systems market size was exhibited at USD 355 million in 2024 and is projected to hit around USD 600.7 million by 2034, growing at a CAGR of 5.4% during the forecast period 2024 to 2034.

The ambulatory polysomnography psg systems market involve polysomnography PSG technology equipment due to the increasing frequency of various types of sleep disorders. The ambulatory polysomnography systems is proportional to the prevalence of sleep disorders. Increasing unhealthy lifestyle (such as obesity, diabetes, and hypertension), work and job stress that causes sleep apnea, and various technological advancements play key role in the diagnosis of sleep apnea. 

• For Instance, On May 2024, the National Council on Aging indicates that approximately 39 million adults in the United States have obstructive sleep apnea (OSA). Additionally, it is estimated that approximately 936 million adults worldwide are affected by mild to severe OSA.  

The demand in the ambulatory polysomnography psg systems market continues to rising awareness sleep disorder is major factors driving the growth of the ambulatory PSG systems market. It has been established that good sleep is the key to good health; support the development of sleep testing by promoting sleep awareness through local level, health organizations, and community forums. This increases the equally convenient and accessible analytical tools, such as ambulatory polysomnography psg systems.